These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 10623648)

  • 1. Intraneuronal Abeta42 accumulation in human brain.
    Gouras GK; Tsai J; Naslund J; Vincent B; Edgar M; Checler F; Greenfield JP; Haroutunian V; Buxbaum JD; Xu H; Greengard P; Relkin NR
    Am J Pathol; 2000 Jan; 156(1):15-20. PubMed ID: 10623648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraneuronal Abeta42 accumulation in Down syndrome brain.
    Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
    Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of intracellular Abeta42 accumulation in Alzheimer's disease.
    Tabira T; Chui DH; Kuroda S
    Front Biosci; 2002 Apr; 7():a44-9. PubMed ID: 11897569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.
    Capetillo-Zarate E; Gracia L; Tampellini D; Gouras GK
    Neurodegener Dis; 2012; 10(1-4):56-9. PubMed ID: 22269167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.
    Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL
    Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
    Gyure KA; Durham R; Stewart WF; Smialek JE; Troncoso JC
    Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both N-terminal and C-terminal fragments of presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease.
    Chui DH; Shirotani K; Tanahashi H; Akiyama H; Ozawa K; Kunishita T; Takahashi K; Makifuchi T; Tabira T
    J Neurosci Res; 1998 Jul; 53(1):99-106. PubMed ID: 9670996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study.
    Iulita MF; Allard S; Richter L; Munter LM; Ducatenzeiler A; Weise C; Do Carmo S; Klein WL; Multhaup G; Cuello AC
    Acta Neuropathol Commun; 2014 Jun; 2():61. PubMed ID: 24903713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combination of Heavy Metals and Intracellular Pathway Modulators Induces Alzheimer Disease-like Pathologies in Organotypic Brain Slices.
    Korde DS; Humpel C
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.
    Murphy MP; Beckett TL; Ding Q; Patel E; Markesbery WR; St Clair DK; LeVine H; Keller JN
    Neurobiol Dis; 2007 Sep; 27(3):301-11. PubMed ID: 17651976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.
    Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK
    Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
    D'Andrea MR; Nagele RG
    Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abeta42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies.
    Schwab C; McGeer PL
    Exp Neurol; 2000 Feb; 161(2):527-34. PubMed ID: 10686074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.